Cloning humans:
p1
Scientists have reproduced clones of primates by artificial twinning but it is proving very difficult to produce a SCNT clone of a primate.
Part of the problem seems to be that the spindle proteins needed for cell division in primate cells are sited very close to the nucleus, so the removal of the nucleus to produce the enucleated primate ovum also destroys the mechanism by which the cell divides.
This is not a problem in the ova of many other mammals because the spindle proteins are more dispersed in the cytoplasm.
Cloning humans:
p2
In addition, the synchronisation of the stage of the embryo and the state of the reproductive organs of the mother have to be exactly attuned in primates - there seems to be more flexibility in some other mammals.
In recent years scientists have finally produced embryonic primate stem cell lines by SCNT.
This means it may eventually be possible to develop these potentially important therapeutic cells from human beings.
Cloning humans:
p3
In most countries there is strict legislation to prevent reproductive cloning of human beings, even if the technical problems of primate cloning are overcome.
A modified version of SCNT has the potential, however, to produce human embryonic stem cells from an adult which could produce cells to be used to grow new tissues for that individual patient.
Research in this process is strictly controlled so it cannot be used for reproductive cloning - it is known as therapeutic cloning to make it clear that the end result is not to reproduce a person.
However, this form of SCNT can potentially make it possible to grow replacement organs which will not trigger an immune response in a patient and which will enable us to cure many currently life-threatening conditions.
Some people claim to have produced a cloned human baby, although they have never produced the child and the adult it was cloned from.
The earliest recorded use of microorganisms by people was around
6000 BC when the Sumerians and Babylonians were using yeast to make beer.
By 4000 BC the Egyptians were using yeast to make their bread rise. These are all examples of the development and use of biotechnology over several millennia.
Defining biotechnology:
The use of microorganisms:
Most biotechnology involves using biological catalysts (enzymes) in a manufacturing process and the most stable, convenient, and effective form of the enzymes is often a whole microorganism.
Microorganisms are ideal for a variety of reasons:
p1
Microorganisms are ideal for a variety of reasons:
p2
Indirect food production:
p1
Indirect food production:
p2
Extra microorganisms:
Sometimes microorganisms are used in the same biotechnological process in more than one way.
Traditionally bacteria are used in cheesemaking (Table 1) and proteolytic enzymes are also added to the milk to help form curds and whey.
Originally these came from rennet, a substance extracted from the stomachs of calves, cows, and pigs containing the enzyme chymosin.
In modern cheesemaking, the chymosin used comes mainly from microorganisms - either from fungal sources or GM bacteria.
process of baking
process of brewing
process of cheese making
process of yoghurt making
Direct food production:
p1
Direct food production:
p2
advantages of using microorganisms directly to make food for human consumption.
disadvantages of using microorganisms directly to make food for human consumption.
Since the discovery of
penicillin in the 1920s, biotechnology has played a key role in the development of medicines.
Producing penicillin:
p1
Producing penicillin:
p2
It is sensitive to pH and temperature.
This affects the way it is produced commercially.
A semi-continuous batch process is used
In the first stage of the production process the fungus grows.
In the second stage it produces penicillin.
Finally the drug is extracted from the medium and purified.
The process uses
relatively small fermenters (40-200 dm*) because it is very difficult to maintain high levels of oxygenation in very large bioreactors.
The mixture is continuously stirred to keep it oxygenated.
There is a rich nutrient medium.
This medium contains a buffer to maintain ph at around 6.5
Biosensors are maintained at around 25-27 degrees C
Making insulin:
p1